{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T07:41:45Z","timestamp":1740123705661,"version":"3.37.3"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,7,20]],"date-time":"2020-07-20T00:00:00Z","timestamp":1595203200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,7,20]],"date-time":"2020-07-20T00:00:00Z","timestamp":1595203200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Familial Cancer"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1007\/s10689-020-00196-z","type":"journal-article","created":{"date-parts":[[2020,7,20]],"date-time":"2020-07-20T02:02:21Z","timestamp":1595210541000},"page":"81-83","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Multiple primary cancers (renal papillary, lymphoma and teratoma) and hepatic cysts in association with a pathogenic germline mutation in the MET gene"],"prefix":"10.1007","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1693-0435","authenticated-orcid":false,"given":"Julian","family":"Adlard","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,7,20]]},"reference":[{"key":"196_CR1","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/ng0597-68","volume":"16","author":"L Schmidt","year":"1997","unstructured":"Schmidt L, Duh F, Chen F et al (1997) Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas. Nat Genet 16:68\u201373","journal-title":"Nat Genet"},{"key":"196_CR2","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/j.eururo.2019.06.015","volume":"76","author":"MI Carlo","year":"2019","unstructured":"Carlo MI, Hakimi AA, Stewart GD et al (2019) Familial kidney cancer: implications of new syndromes and molecular insights. Eur Urol 76:754\u2013764","journal-title":"Eur Urol"},{"key":"196_CR3","doi-asserted-by":"publisher","first-page":"205","DOI":"10.21037\/atm.2017.03.64","volume":"5","author":"EA Tovar","year":"2017","unstructured":"Tovar EA, Graveel CR (2017) MET in human cancer: germline and somatic mutations. Ann Transl Med 5:205","journal-title":"Ann Transl Med"},{"key":"196_CR4","unstructured":"Cancer Research UK (2018) Testicular cancer risk. https:\/\/www.cancerresearchuk.org\/health-professional\/cancer-statistics\/statistics-by-cancer-type\/testicular-cancer\/risk-factors. Accessed 8th April 2020"},{"key":"196_CR5","unstructured":"Cancer Research UK (2018) Non-Hodgkin lymphoma risk. https:\/\/www.cancerresearchuk.org\/health-professional\/cancer-statistics\/statistics-by-cancer-type\/non-hodgkin-lymphoma\/risk-factors. Accessed 8th April 2020"},{"key":"196_CR6","doi-asserted-by":"publisher","first-page":"38","DOI":"10.3389\/fendo.2014.00038","volume":"5","author":"G Ricci","year":"2014","unstructured":"Ricci G, Catizone A (2014) Pleiotropic activities of HGF\/c-Met system in testicular physiology: paracrine and endocrine implications. Front Endocrinol 5:38","journal-title":"Front Endocrinol"},{"key":"196_CR7","doi-asserted-by":"publisher","first-page":"31842","DOI":"10.18632\/oncotarget.25867","volume":"9","author":"KC Scheri","year":"2018","unstructured":"Scheri KC, Leonetti E, Laino L et al (2018) c-MET receptor as potential biomarker and target molecule for malignant testicular germ cell tumors. Oncotarget 9:31842\u201331860","journal-title":"Oncotarget"},{"key":"196_CR8","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1111\/andr.12663","volume":"7","author":"MK Das","year":"2019","unstructured":"Das MK, Kleppa L, Haugen TB (2019) Functions of genes related to testicular germ cell tumour development. Andrology 7:527\u2013535","journal-title":"Andrology"},{"key":"196_CR9","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1471-2490-13-9","volume":"13","author":"N Zeh","year":"2013","unstructured":"Zeh N, Wild PJ, Bode PK et al (2013) Retroperitoneal teratoma with somatic malignant transformation: a papillary renal cell carcinoma in a testicular germ cell tumour metastasis following platinum-based chemotherapy. BMC Urol 13:9","journal-title":"BMC Urol"},{"key":"196_CR10","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/S0065-230X(00)79002-6","volume":"79","author":"R van der Voort","year":"2000","unstructured":"van der Voort R, Taher TE, Derksen PW et al (2000) The hepatocyte growth factor\/Met pathway in development, tumorigenesis, and B-cell differentiation. Adv Cancer Res 79:39\u201390","journal-title":"Adv Cancer Res"},{"key":"196_CR11","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1038\/labinvest.2010.108","volume":"90","author":"S Uddin","year":"2010","unstructured":"Uddin S, Hussain AR, Ahmed M et al (2010) Inhibition of c-MET is a potential therapeutic strategy for treatment of diffuse large B-cell lymphoma. Lab Invest 90:1346\u20131356","journal-title":"Lab Invest"},{"key":"196_CR12","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/s13045-016-0366-y","volume":"9","author":"BQ Lam","year":"2016","unstructured":"Lam BQ, Dai L, Qin Z (2016) The role of HGF\/c-MET signaling pathway in lymphoma. J Hematol Oncol 9:135","journal-title":"J Hematol Oncol"},{"key":"196_CR13","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1002\/hep.29496","volume":"67","author":"M Bouattour","year":"2018","unstructured":"Bouattour M, Raymond E, Qin S et al (2018) Recent developments of c-Met as a therapeutic target in hepatocellular carcinoma. Hepatology 67:1132\u20131149","journal-title":"Hepatology"},{"issue":"10","key":"196_CR14","doi-asserted-by":"publisher","first-page":"e13586","DOI":"10.1371\/journal.pone.0013586","volume":"5","author":"CR Graveel","year":"2010","unstructured":"Graveel CR, DeGroot JD, Sigler RE et al (2010) Germline met mutations in mice reveal mutation - and background-associated differences in tumor profiles. PLoS ONE 5(10):e13586","journal-title":"PLoS ONE"},{"key":"196_CR15","doi-asserted-by":"publisher","first-page":"4504","DOI":"10.1158\/1078-0432.CCR-18-3261","volume":"25","author":"M El Bouchtaoui","year":"2019","unstructured":"El Bouchtaoui M, Do Cruzeiro M, Leboeuf C et al (2019) A constitutional activating MET mutation makes the genetic link between malignancies and chronic inflammatory diseases. Clin Cancer Res 25:4504\u20134515","journal-title":"Clin Cancer Res"},{"issue":"8","key":"196_CR16","doi-asserted-by":"publisher","first-page":"E26","DOI":"10.1136\/jmg.38.8.e26","volume":"38","author":"JD Chen","year":"2001","unstructured":"Chen JD, Kearns S, Porter T et al (2001) MET mutation and familial gastric cancer. J Med Genet 38(8):E26","journal-title":"J Med Genet"},{"key":"196_CR17","doi-asserted-by":"publisher","first-page":"2301","DOI":"10.1158\/1078-0432.CCR-15-1841","volume":"22","author":"RA Toledo","year":"2016","unstructured":"Toledo RA, Qin Y, Cheng ZM et al (2016) Recurrent mutations of chromatin-remodeling genes and kinase receptors in pheochromocytomas and paragangliomas. Clin Cancer Res 22:2301\u20132310","journal-title":"Clin Cancer Res"},{"key":"196_CR18","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1001\/jamaoncol.2015.4771","volume":"2","author":"J Whitworth","year":"2016","unstructured":"Whitworth J, Skytte AB, Sunde L et al (2016) Multilocus inherited neoplasia alleles syndrome: a case series and review. JAMA Oncol 2:373\u2013379","journal-title":"JAMA Oncol"}],"container-title":["Familial Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-020-00196-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10689-020-00196-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-020-00196-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,19]],"date-time":"2021-07-19T23:40:12Z","timestamp":1626738012000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10689-020-00196-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,20]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["196"],"URL":"https:\/\/doi.org\/10.1007\/s10689-020-00196-z","relation":{},"ISSN":["1389-9600","1573-7292"],"issn-type":[{"type":"print","value":"1389-9600"},{"type":"electronic","value":"1573-7292"}],"subject":[],"published":{"date-parts":[[2020,7,20]]},"assertion":[{"value":"9 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The author declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Exempt for anonymised case report","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Written consent was obtained from the patient","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}